- Advanced search
|International Nonproprietary Names|
|Search PubMed clinical trials||aducanumab|
|Search PubMed titles||aducanumab|
|Search PubMed titles/abstracts||aducanumab|
|Aducanumab is a fully human IgG1-kappa monoclonal antibody directed against the amyloid beta (Aβ) found in the amyloid plaques in the brain tissue of patients with Alzheimer's disease (AD).
Peptide sequences and structural information about this antibody are available from its IMGT/mAb-DB record. A patent search reveals Biogen Idec's patent submission WO2014089500 .